A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)

Joel M. Gelfand, Daniel B. Shin, Kristina Callis Duffin, April W. Armstrong, Andrew Blauvelt, Stephen K. Tyring, Alan Menter, Scott Gottlieb, Benjamin N. Lockshin, Eric L. Simpson, Farid Kianifard, Rajendra Prasad Sarkar, Elisa Muscianisi, Jennifer Steadman, Mark A. Ahlman, Martin P. Playford, Aditya A. Joshi, Amit K. Dey, Thomas J. Werner, Abass AlaviNehal N. Mehta

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds